journal article·2022-01-25Open access

Updates and Original Case Studies Focused on the NMR-Linked Metabolomics Analysis of Human Oral Fluids Part I: Emerging Platforms and Perspectives

Martin Grootveld, Georgina Page, Mohammed Bhogadia, Mark Edgar

Applied Sciences· Volume 12· Issue 3

Abstract

1H NMR-based metabolomics analysis of human saliva, other oral fluids, and/or tissue biopsies serves as a valuable technique for the exploration of metabolic processes, and when associated with ’state-of-the-art’ multivariate (MV) statistical analysis strategies, provides a powerful means of examining the identification of characteristic metabolite patterns, which may serve to differentiate between patients with oral health conditions (e.g., periodontitis, dental caries, and oral cancers) and age-matched heathy controls. This approach may also be employed to explore such discriminatory signatures in the salivary 1H NMR profiles of patients with systemic diseases, and to date, these have included diabetes, Sjörgen’s syndrome, cancers, neurological conditions such as Alzheimer’s disease, and viral infections. However, such investigations are complicated in view of quite a large number of serious inconsistencies between the different studies performed by independent research groups globally; these include differing protocols and routes for saliva sample collection (e.g., stimulated versus unstimulated samples), their timings (particularly the oral activity abstention period involved, which may range from one to 12 h or more), and methods for sample transport, storage, and preparation for NMR analysis, not to mention a very wide variety of demographic variables that may influence salivary metabolite concentrations, notably the age, gender, ethnic origin, salivary flow-rate, lifestyles, diets, and smoking status of participant donors, together with their exposure to any other possible convoluting environmental factors. In view of the explosive increase in reported salivary metabolomics investigations, in this update, we critically review a wide range of critical considerations for the successful performance of such experiments. These include the nature, composite sources, and biomolecular status of human saliva samples; the merits of these samples as media for the screening of disease biomarkers, notably their facile, unsupervised collection; and the different classes of such metabolomics investigations possible. Also encompassed is an account of the history of NMR-based salivary metabolomics; our recommended regimens for the collection, transport, and storage of saliva samples, along with their preparation for NMR analysis; frequently employed pulse sequences for the NMR analysis of these samples; the supreme resonance assignment benefits offered by homo- and heteronuclear two-dimensional NMR techniques; deliberations regarding salivary biomolecule quantification approaches employed for such studies, including the preprocessing and bucketing of multianalyte salivary NMR spectra, and the normalization, transformation, and scaling of datasets therefrom; salivary phenotype analysis, featuring the segregation of a range of different metabolites into ‘pools’ grouped according to their potential physiological sources; and lastly, future prospects afforded by the applications of LF benchtop NMR spectrometers for direct evaluations of the oral or systemic health status of patients at clinical ‘point-of-contact’ sites, e.g., dental surgeries. This commentary is then concluded with appropriate recommendations for the conduct of future salivary metabolomics studies. Also included are two original case studies featuring investigations of (1) the 1H NMR resonance line-widths of selected biomolecules and their possible dependence on biomacromolecular binding equilibria, and (2) the combined univariate (UV) and MV analysis of saliva specimens collected from a large group of healthy control participants in order to potentially delineate the possible origins of biomolecules therein, particularly host- versus oral microbiome-derived sources. In a follow-up publication, Part II of this series, we conduct censorious reviews of reported observations acquired from a diversity of salivary metabolomics investigations performed to evaluate both localized oral and non-oral diseases. Perplexing problems encountered with these again include those arising from sample collection and preparation protocols, along with 1H NMR spectral misassignments.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Metabolomics and Mass Spectrometry Studies · Salivary Gland Disorders and Functions · Oral microbiology and periodontitis research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Leicester School of Pharmacy, De Montfort University, The Gateway, Leicester LE1 9BH, UK

References (100+)

Show source-provided references
1. Wilson, P.B., and Grootveld, M. (2020). Computational Techniques for Analytical Chemistry and Bioanalysis, Royal Society of Chemistry.10.1039/9781788015882 ↗
2. 1H NMR analysis of microbial-derived organic acids in primary root carious lesions and saliva10.1002/(SICI)1099-1492(199910)12:6<345::AID-NBM580>3.0.CO;2-C ↗
3. 1H and 13C NMR spectroscopic analysis of human saliva10.1177/154405910208100613 ↗
4. 1H NMR analysis as an analytical probe for human saliva10.1016/j.bbrc.2005.01.112 ↗
5. 1H NMR Investigations of the molecular nature of low-molecular-mass calcium ions in biofluids10.1007/s007750100264 ↗
6. The human saliva metabolome10.1007/s11306-015-0840-5 ↗
7. Gardner, A., Carpenter, G., and So, P.W. (2020). Salivary metabolomics: From diagnostic biomarker discovery to investigating biological function. Metabolites, 10.10.3390/metabo10020047 ↗
8. Self organising maps for variable selection: Application to human saliva analysed by nuclear magnetic resonance spectroscopy to investigate the effect of an oral healthcare product10.1016/j.chemolab.2009.06.002 ↗
9. Supervised Self Organizing Maps (SOMs) for classification and variable selection: Illustrated by application to NMR metabolomic profiling10.1021/ac9020566 ↗
10. Chemometric variance analysis of 1H NMR metabolomics data on the effects of oral rinse on saliva10.1007/s11306-011-0358-4 ↗
11. FuGePSD: Fuzzy genetic programming-base for subgroup discovery. A case study: Pathogenesis of acute sore throat conditions in humans10.1016/j.ins.2014.11.030 ↗
12. Saliva metabolomics opens door to biomarker discovery, disease diagnosis, and treatment10.1007/s12010-012-9891-5 ↗
13. 1H NMR investigations of the molecular nature of cobalt(II) ions in human saliva10.1016/j.abb.2012.02.002 ↗
14. Saliva A review of its role in maintaining oral health and preventing dental disease10.1038/bdjteam.2015.123 ↗
15. The physiology of salivary secretion10.1111/prd.12116 ↗
16. Methods for collecting saliva10.1111/j.1749-6632.1993.tb18343.x ↗
17. Salivary pH: A diagnostic biomarker10.4103/0972-124X.118317 ↗
18. Jenkins, G.N. (1978). The Physiology and Biochemistry of the Mouth, Blackwell Scientific. [4th ed.].
19. Serum
20. Determining bacterial and host contributions to the human salivary metabolome10.1080/20002297.2019.1617014 ↗
21. Diagnostic biomarkers of Alzheimer’s disease as identified in saliva using 1H NMR-based metabolomics10.3233/JAD-161226 ↗
22. Preliminary nuclear magnetic resonance studies on human saliva10.1016/0003-9969(91)90025-P ↗
23. Metabolite quantification by nmr and lc-ms/ms reveals differences between unstimulated, stimulated, and pure parotid saliva10.1016/j.jpba.2017.03.037 ↗
24. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism10.1080/19490976.2015.1134082 ↗
25. Colon microbiota fermentation of dietary prebiotics towards short-chain fatty acids and their roles as anti-inflammatory and antitumour agents: A review10.1016/j.jff.2016.06.032 ↗
26. From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites10.1016/j.cell.2016.05.041 ↗
27. Microbiota-gut-brain axis: Modulator of host metabolism and appetite10.3945/jn.116.240481 ↗
28. Formation of propionate and butyrate by the human colonic microbiota10.1111/1462-2920.13589 ↗
29. Oral microbiome metabolism: From “who are they?” to “what are they doing?”10.1177/0022034515606045 ↗
30. Individual human metabolic phenotype analyzed by 1H NMR of saliva samples10.1021/acs.jproteome.5b01060 ↗
31. Developing and standardizing a protocol for quantitative proton nuclear magnetic resonance (1h nmr) spectroscopy of saliva10.1021/acs.jproteome.7b00847 ↗
32. Formation of methylamines from ingested choline and lecithin
33. Metabolic, epigenetic, and transgenerational effects of gut bacterial choline consumption10.1016/j.chom.2017.07.021 ↗
34. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota10.1073/pnas.1316569111 ↗
35. Production of butyrate from lysine and the Amadori product fructoselysine by a human gut commensal10.1038/ncomms10062 ↗
36. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data10.1128/mBio.00889-14 ↗
37. The scientific exploration of saliva in the post-proteomic era: From database back to basic function10.1586/epr.11.80 ↗
38. Mixed aerobic-anaerobic incubation conditions induce proteolytic activity from in vitro salivary biofilms10.1080/20002297.2019.1643206 ↗
39. Oral transmission of HIV, reality or fiction? An update10.1111/j.1601-0825.2005.01187.x ↗
40. Saliva testing—A non traditional diagnostic tool
41. Age-related changes in immunoglobulin isotypes in whole and parotid saliva and serum in healthy individuals10.1111/j.1399-302X.1995.tb00143.x ↗
42. Saliva: An emerging biofluid for early detection of diseases
43. The application of saliva, sweat, and tear fluid for diagnostic purposes
44. Salivary biomarkers: Toward future clinical and diagnostic utilities10.1128/CMR.00021-13 ↗
45. Therapeutic drug monitoring in saliva: An update10.2165/00003088-199223050-00003 ↗
46. Pharmacokinetic principles of drug distribution in saliva10.1111/j.1749-6632.1993.tb18340.x ↗
47. HMDB 4.0—The Human Metabolome Database for 201810.1093/nar/gkx1089 ↗
48. Untargeted metabolomics strategies-challenges and emerging directions10.1007/s13361-016-1469-y ↗
49. Metabolomics: Current analytical platforms and methodologies10.1016/j.trac.2004.11.021 ↗
50. Multicomponent spectroscopic investigations of salivary antioxidant consumption by an oral rinse preparation containing the stable free radical species chlorine dioxide (ClO2∙)10.3109/10715769709097801 ↗
51. Multicomponent evaluations of the oxidising actions and status of a peroxoborate-containing tooth-whitening system in whole human saliva using high resolution proton NMR spectroscopy10.1016/S0162-0134(98)10092-2 ↗
52. Precision high-throughput proton nmr spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping10.1021/ac5025039 ↗
53. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts10.1038/nprot.2007.376 ↗
54. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry10.1038/nprot.2011.335 ↗
55. Global urinary metabolic profiling procedures using gas chromatography–mass spectrometry10.1038/nprot.2011.375 ↗
56. Study of sample preparation for metabolomic profiling of human saliva by liquid chromatography–time of flight/mass spectrometry10.1016/j.chroma.2012.05.029 ↗
57. Williams, R.A.D., and Elliottt, J.C. (1979). Basic and Applied Dental Biochemistry, Churchill Livingstone.
58. Detection and determination of methanol and further potential toxins in human saliva collected from cigarette smokers: A 1H NMR investigation
59. Identification of salivary metabolomic biomarkers for oral cancer screening10.1038/srep31520 ↗
60. Duarte, D., Castro, B., Pereira, J.L., Marques, J.F., Costa, A.L., and Gil, A.M. (2020). Evaluation of saliva stability for nmr metabolomics: Collection and handling protocols. Metabolites, 10.10.3390/metabo10120515 ↗
61. Salivary metabolite fingerprint of type 1 diabetes in young children10.1021/acs.jproteome.6b00007 ↗
62. Metabolomic status of the oral cavity in chronic periodontitis10.21873/invivo.11587 ↗
63. Salivary metabolome of children and adolescents under peritoneal dialysis10.1007/s00784-020-03557-1 ↗
64. Salivary and Serum Biochemical Analysis from Patients with Chronic Renal Failure in Hemodialysis: A Cross-Sectional Study
65. Metabolomics analysis of the saliva in patients with chronic hepatitis by using nuclear magnetic resonance: A pilot study
66. Targeted metabolomics of pellicle and saliva in children with different caries activity10.1038/s41598-020-57531-8 ↗
67. The saliva metabolome in association to oral health status10.1177/0022034519842853 ↗
68. Metabolomics-based screening of salivary biomarkers for early diagnosis of Alzheimer’s disease10.1039/C5RA19094K ↗
69. Oral squamous cell carcinoma diagnosed from saliva metabolic profiling10.1073/pnas.2001395117 ↗
70. Salivary metabolomics with alternative decision tree-based machine learning methods for breast cancer discrimination10.1007/s10549-019-05330-9 ↗
71. Analysis of salivary phenotypes of generalized aggressive and chronic periodontitis through nuclear magnetic resonance-based metabolomics10.1002/JPER.18-0097 ↗
72. Alzheimer’s biomarkers from multiple modalities selectively discriminate clinical status: Relative importance of salivary metabolomics panels, genetic, lifestyle, cognitive, functional health and demographic risk markers10.3389/fnagi.2018.00296 ↗
73. Salivary metabolite levels in perinatally HIV-infected youth with periodontal disease10.1007/s11306-020-01719-6 ↗
74. Metabolomics analysis of saliva from patients with primary Sjögren’s syndrome.10.1111/cei.12683 ↗
75. Salivary metabolite signatures of oral cancer and leukoplakia10.1002/ijc.25881 ↗
76. Assad, D.X., Acevedo, A.C., Mascarenhas, E.C.P., Normando, A.G.C., Pichon, V., Chardin, H., Guerra, E.N.S., and Combes, A. (2020). Using an untargeted metabolomics approach to identify salivary metabolites in women with breast cancer. Metabolites, 10.10.3390/metabo10120506 ↗
77. Post-periodontal surgery propounds early repair salivary biomarkers by 1H NMR based metabolomics10.1007/s11306-019-1593-3 ↗
78. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles10.1007/s11306-009-0178-y ↗
79. Effects of inter-day and intra-day variation on salivary metabolomic profiles10.1016/j.cca.2018.11.030 ↗
80. Metabolome of canine and human saliva: A non-targeted metabolomics study10.1007/s11306-020-01711-0 ↗
81. Salivary metabolic profile of children and adolescents after hemodialysis10.1007/s11306-017-1283-y ↗
82. Discrimination of oral squamous cell carcinoma from oral lichen planus by salivary metabolomics10.1111/odi.13209 ↗
83. Jo, J., Seo, S.-H., Park, S.-E., Kim, H.-W., Kim, E.-J., Na, C.-S., Cho, K.-M., Kwon, S.-J., Moon, Y.-H., and Son, H.-S. (2021). Identification of Salivary Microorganisms and Metabolites Associated with Halitosis. Metabolites, 11.10.3390/metabo11060362 ↗
84. Effect of timing of collection of salivary metabolomic biomarkers on oral cancer detection10.1007/s00726-017-2378-5 ↗
85. Longitudinal evaluation of salivary profile from children with dental caries before and after treatment10.1007/s11306-014-0717-z ↗
86. Endogenous salivary citrate is associated with enhanced rheological properties following oral capsaicin stimulation10.1113/EP088166 ↗
87. Understanding the human salivary metabolome10.1002/nbm.1369 ↗
88. 1H-NMR-Based salivary metabolomics from females with temporomandibular disorders—A pilot study10.1016/j.cca.2020.08.006 ↗
89. Quantitative metabolomics of saliva using proton NMR spectroscopy in patients with Parkinson’s disease and healthy controls10.1007/s10072-019-04143-4 ↗
90. Validated ultra-high-performance liquid chromatography hybrid high-resolution mass spectrometry and laser-assisted rapid evaporative ionization mass spectrometry for salivary metabolomics10.1021/acs.analchem.9b05598 ↗
91. Effect of experimental gingivitis induction and erythritol on the salivary metabolome and functional biochemistry of systemically healthy young adults10.1007/s11306-016-1096-4 ↗
92. Variability of salivary metabolite levels in patients with Sjögren’s syndrome10.2334/josnusd.19-0504 ↗
93. Saliva metabolomics by NMR for the evaluation of sport performance10.1016/j.jpba.2013.09.021 ↗
94. Potential role of nuclear magnetic resonance spectroscopy to identify salivary metabolite alterations in patients with head and neck cancer
95. Ishikawa, S., Hiraka, T., Kirii, K., Sugimoto, M., Shimamoto, H., Sugano, A., Kitabatake, K., Toyoguchi, Y., Kanoto, M., and Nemoto, K. (2020). Relationship between standard uptake values of positron emission tomography/computed tomography and salivary metabolites in oral cancer: A pilot study. J. Clin. Med., 9.10.3390/jcm9123958 ↗
96. Troisi, J., Belmonte, F., Bisogno, A., Pierri, L., Colucci, A., Scala, G., Cavallo, P., Mandato, C., Nuzzi, A.D., and Michele, L.D. (2019). Metabolomic salivary signature of pediatric obesity related liver disease and metabolic syndrome. Nutrients, 11.10.3390/nu11020274 ↗
97. The buffer capacity and buffer systems of human whole saliva measured without loss of CO210.1016/S0003-9969(99)00119-3 ↗
98. Effect of two mouthwashes on salivary pH
99. Salivary thiols and enzyme markers of cell damage in periodontal disease10.1016/j.clinbiochem.2007.01.011 ↗
100. High resolution 1H NMR investigations of the reactivities of a-keto acid anions with hydrogen peroxide10.3109/10715769709097793 ↗